EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has completed its previously announced acquisition...
EMERYVILLE, Calif., June 12, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“ XOMA ” or the “ Company ”) today announced that its Board of Directors has authorized the following...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK , June 10, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...
Barchart Research What to Expect from XOMA Earnings XOMA Generated May 18, 2026 Current Price $41.64 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 6.02% Can XOMA's Late-Stage Pipeline...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
Barchart Research What to Expect from XOMA Earnings XOMA Generated May 11, 2026 Current Price $41.51 EPS Estimate $$0.19 Consensus Rating Moderate Buy Average Move 6.02% XOMA's Liquidation Pivot May Be...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
NEW YORK , May 6, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars...
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.